ArticlePharmaceutics2024

Functionalized PLGA-Based Nanoparticles with Anti-HSV-2 Human Monoclonal Antibody: A Proof of Concept for Early Diagnosis and Targeted Therapy.

Melinda Mariotti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.